Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation.

Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation. Abstract Text:

BACKGROUND: Leukotriene B4 (LTB4) is a potent inflammatory mediator that also stimulates the immune response. In addition, it promotes polymorphonuclear leukocyte phagocytosis, chemotaxis, chemokinesis and modulates cytokines release. Regarding chemical instability of the leukotriene molecule, in the present study we assessed the immunomodulatory activities conferred by LTB4 released from microspheres (MS). A previous oil-in-water emulsion solvent extraction-evaporation method was chosen to prepare LTB4-loaded MS. RESULTS: In the mice cremasteric microcirculation, intraescrotal injection of 0.1 ml of LTB4-loaded MS provoked significant increases in leukocyte rolling flux, adhesion and emigration besides significant decreases in the leukocyte rolling velocity. LTB4-loaded MS also increase peroxisome proliferator-activated receptor-alpha (PPARalpha) expression by murine peritoneal macrophages and stimulate them to generate nitrite levels. Monocyte chemoattractant protein-1 (MCP-1) and nitric oxide (NO) productions were also increased when human umbilical vein and artery endothelial cells (HUVECs and HUAECs, respectively) were stimulated with LTB4-loaded MS. CONCLUSION: LTB4-loaded MS preserve the biological activity of the encapsulated mediator indicating their use as a new strategy to modulate cell activation, especially in the innate immune response.

Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: BMC immunology

VOLUME: 9

Page Numbers: 36

Journal Abbreviation: BMC Immunol.

ISSN: 1471-2172

DAY: 15

MONTH: 07

YEAR: 2008

Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100966980

Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation.

AFFILIATION: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Av, do Café s/n, 14040-903, Ribeirão Preto, São Paulo, Brasil. nicolete@fcfrp.usp.br; Cristina Rius

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: BMC Immunol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation Related Publications

• Anti-asthmatic potential of a D-galactose-binding lectin from Synadenium carinatum latex.
• Anti-eosinophilic effect of Lafoensia pacari in toxocariasis.
• Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma.
• Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma.
• Comparison of immune responses in mice infected with different strains of Strongyloides venezuelensis.
• Cost effectiveness of multimodal intraoperative monitoring during spine surgery.
• Effect of a leukotriene inhibitor (MK886) on nitric oxide and hydrogen peroxide production by macrophages of acutely and chronically stressed mice.
• Gr-1(+) cells play an essential role in an experimental model of disseminated histoplasmosis.
• Inflammatory response to different endodontic irrigating solutions.
• Inhibition of leukotriene biosynthesis abrogates the host control of Mycobacterium tuberculosis.
• Leukotriene B4-loaded microspheres: a new therapeutic strategy to modulate cell activation.
• Mast cells modulate pulmonary acute inflammation and host defense in a murine model of tuberculosis.
• The immune response to toxocariasis does not modify susceptibility to Mycobacterium tuberculosis infection in BALB/c mice.
• pcDNA-IL-12 vaccination blocks eosinophilic inflammation but not airway hyperresponsiveness following murine Toxocara canis infection.